Article
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
21 Dec 2022
Abstract excerpt
Background and ObjectivesUncontrolled evidence suggests that autologous hematopoietic stem cell transplantation (AHSCT) can be effective in people with active secondary progressive multiple sclerosis (SPMS). In this study, we compared the effect of AHSCT with that of other anti-inflammatory disease-modifying therapies (DMTs) on long-term disability worsening in active SPMS. MethodsWe collected data from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
